SEC Form 4/A · accession 0001209191-18-051751
SOPHIRIS BIO INC. · SPHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Randall E Woods
Officer — President & Chief Exec Officer · Director
Period of report
Sep 19, 2018
Accepted (ET)
Sep 20, 2018 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563855
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 19, 2018 | P | 10,000 | $2.6339 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to correct the original wording in the footnote: The weighted average purchase price for the transaction reported was $2.6339, and the range of prices were between $2.565 and $2.74. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.